event,time
76 years old ,0
male ,0
admitted to the hospital ,0
severe hyponatremia ,0
pancreatic adenocarcinoma ,-672
metastasis to the liver ,-672
diastolic heart failure ,-672
atrial fibrillation ,-672
coronary artery disease ,-672
port placement for chemotherapy ,-672
routine preoperative evaluation ,-672
sodium level of 116 mmol/L ,-672
pneumonia ,-672
x-ray findings ,-672
broad-spectrum antibiotics ,-672
fluid for hyponatremia ,-672
transferred to the intensive care unit ,-672
jugular vein distention ,-672
lower extremity pitting edema ,-672
transthoracic echocardiogram ,-672
normal left ventricular cavity size ,-672
mildly reduced systolic function ,-672
septal flattening ,-672
left atrial enlargement ,-672
suspected MV vegetation ,-672
severe mitral regurgitation ,-672
tricuspid regurgitation Doppler ,-672
elevated RV systolic pressure ,-672
type 2 and type 3 pulmonary arterial hypertension ,-672
ill-defined thickening in the TV leaflets ,-672
afebrile ,-672
leukocytosis ,-672
recent urethral instrumentation ,-672
blood cultures ,-672
consulted infectious disease specialist ,-672
broad-spectrum antibiotics ,-672
infective endocarditis ,-672
day 1 ,-672
valvular vegetations via echocardiography ,-672
tricuspid valve (TV) and mitral valve (MV) ,-672
transesophageal echocardiogram (TEE) ,-24
normal left ventricular size and function ,-24
normal RV size and function ,-24
hypermobile interatrial septum ,-24
no left atrial or left atrial appendage thrombus ,-24
2 large vegetations on the atrial aspect of MV leaflets ,-24
severe mitral regurgitation ,-24
tricuspid regurgitation ,-24
RVSP 47 mm Hg ,-24
negative blood cultures ,-24
polymerase chain reaction testing ,-24
Coxiella urnetiid ,-24
Legionella spp ,-24
Brucella spp ,-24
antiphospholipid syndrome ,-24
discontinued apixaban ,-24
low molecular weight heparin or unfractionated heparin ,-24
computed tomography imaging of the head ,-24
intracerebral hemorrhage ,-24
observation of clinic course ,-24
enoxaparin ,-24
"platelets recovered to above 50,000 10^9/L ",-24
nonbacterial thrombotic endocarditis (NBTE) ,-24
advanced malignancy ,-24
systemic lupus erythematosus ,-24
antiphospholipid syndrome ,-24
rheumatoid arthritis ,-24
sepsis ,-24
burns ,-24
echocardiogram ,-24
infectious endocarditis ,-24
valvular destruction ,-24
unfractionated heparin ,-24
vitamin K antagonists ,-24
warfarin ,-24
surgical intervention ,-24
heart failure ,-24
acute valve rupture ,-24
prevention of recurrent embolization ,-24
bivalvular involvement ,-24
valvular dysfunction ,-24
valvular regurgitation ,-24
anticoagulation ,-24
resolution of valvular dysfunction ,-24
advanced pancreatic malignancy ,-24
outpatient follow-up ,-24
death ,-24
